Close
Nordic 9Nordic 9

Innomedical (investor - Corporate Investor)

Switzerland
See something wrong or missing? Let us know
Offices:Geneva
Average round investment:10.87M USD
Average number per year:1.0
Distribution: 2024 (1)
Portfolio companies: Belgium CryoTherapeutics
Mostly invests in: Belgium Belgium (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Innomedical

Name Criteria
Portugal Buenavista Equity Partners
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Peppermint Venture Partners
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Riyadh Valley Company
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Social Impact Capital
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Fifty Years
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Adjacent
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 3.4
  • Active last 12 months: Yes
Switzerland Debiopharm Innovation Fund
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland Yellowstone Holding
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
France Anaxago
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Belgium Novalis Biotech
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top